IMMUNOGENICITY AND TOXICITY OF LIPOPOLYSACCHARIDE FROM FRANCISELLA-TULARENSIS LVS

被引:35
|
作者
SANDSTROM, G
SJOSTEDT, A
JOHANSSON, T
KUOPPA, K
WILLIAMS, JC
机构
[1] US FDA, CTR BIOL EVALUAT & RES, BETHESDA, MD 20014 USA
[2] UMEA UNIV, DEPT INFECT DIS, S-90187 UMEA, SWEDEN
[3] USA, MED RES INST INFECT DIS, INTRACELLULAR PATHOGENS BRANCH, FREDERICK, MD 21701 USA
来源
FEMS MICROBIOLOGY IMMUNOLOGY | 1992年 / 105卷 / 04期
关键词
LIPOPOLYSACCHARIDE; TULAREMIA; FRANCISELLA-TULARENSIS; ENDOTOXIN; TNF; IL-1;
D O I
10.1111/j.1574-6968.1992.tb05902.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lipopolysaccharide (LPS) from the live vaccine strain of Francisella tularensis (F. tularensis LVS) was isolated and purified. The LPS did not stimulate lymphocytes from previously tularaemia-vaccinated individuals or lymphocytes from non-primed individuals. However, serum antibodies from tularaemia vaccinees reacted with the LPS whereas virtually no reactivity was found with antibodies from individuals not exposed to F. tularensis LVS. Antibodies of immunoglobulin class M displayed the antibody reactivity predominantly. The LPS failed to induce the mononuclear cell-derived cytokine interleukin-1 and only low levels of tumour necrosis factor were detected. Furthermore, no LPS endotoxin properties were found in galactosamine-treated mice or in the Limulus amoebocyte lysate assay. From these results it can be concluded that F. tularensis LVS possesses a lipopolysaccharide-like molecule, which does not exhibit properties of a classical endotoxin.
引用
收藏
页码:201 / 210
页数:10
相关论文
共 50 条
  • [31] GROWTH OF FRANCISELLA-TULARENSIS LVS IN MACROPHAGES - THE ACIDIC INTRACELLULAR COMPARTMENT PROVIDES ESSENTIAL IRON REQUIRED FOR GROWTH
    FORTIER, AH
    LEIBY, DA
    NARAYANAN, RB
    ASAFOADJEI, E
    CRAWFORD, RM
    NACY, CA
    MELTZER, MS
    [J]. INFECTION AND IMMUNITY, 1995, 63 (04) : 1478 - 1483
  • [32] NATURAL PENICILLIN RESISTANCE OF FRANCISELLA-TULARENSIS
    PAVLOVICH, NV
    TKACHEVA, TI
    [J]. ANTIBIOTIKI I KHIMIOTERAPIYA, 1990, 35 (08) : 25 - 28
  • [33] NATURE OF PROTECTIVE IMMUNITY TO FRANCISELLA-TULARENSIS
    TARNVIK, A
    [J]. REVIEWS OF INFECTIOUS DISEASES, 1989, 11 (03): : 440 - 451
  • [34] PREPARATION OF FRANCISELLA-TULARENSIS NONCAPSULAR VARIANTS
    PAVLOVICH, NV
    MISHANKIN, BN
    DANILEVSKAYA, GI
    KHODOVA, VA
    RYZHKOVA, VV
    TSIMBALISTOVA, MI
    SUKHAR, VV
    [J]. ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, 1993, (02): : 7 - 11
  • [35] H-2-RESTRICTION IN ACQUIRED CELL-MEDIATED-IMMUNITY TO INFECTION WITH FRANCISELLA-TULARENSIS LVS
    ANTHONY, LSD
    KONGSHAVN, PAL
    [J]. INFECTION AND IMMUNITY, 1988, 56 (02) : 452 - 456
  • [36] USE OF IMMUNOELECTRON MICROSCOPY TO DEMONSTRATE FRANCISELLA-TULARENSIS
    GEISBERT, TW
    JAHRLING, PB
    EZZELL, JW
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (07) : 1936 - 1939
  • [37] FURTHER STUDY OF THE INTERSPECIFIC TAXONOMY OF FRANCISELLA-TULARENSIS
    OLSUFYEV, NG
    MESHCHERYAKOVA, IS
    [J]. ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, 1981, (10): : 16 - 21
  • [38] Sequence comparison of Francisella tularensis LVS, LVS-G and LVS-R
    Kurtz, Sherry L.
    Voskanian-Kordi, Alin
    Simonyan, Vahan
    Elkins, Karen L.
    [J]. PATHOGENS AND DISEASE, 2018, 76 (07):
  • [39] DETERMINATION OF THE ANTIGENIC DETERMINANT OF PREVENTIVE MONOCLONAL-ANTIBODIES, SPECIFIC TO FRANCISELLA-TULARENSIS LIPOPOLYSACCHARIDE
    KHLEBNIKOV, VS
    GOLOVLEV, IR
    TOKHTAMYSHEVA, NV
    AVERIN, SF
    KULEVATSKY, DP
    GRECHKO, GK
    AVERINA, AA
    VETCHININ, SS
    [J]. ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, 1993, (01): : 83 - 88
  • [40] MEMBRANE-PROTEINS OF FRANCISELLA-TULARENSIS LVS DIFFER IN ABILITY TO INDUCE PROLIFERATION OF LYMPHOCYTES FROM TULAREMIA-VACCINATED INDIVIDUALS
    SURCEL, HM
    SARVAS, M
    HELANDER, IM
    HERVA, E
    [J]. MICROBIAL PATHOGENESIS, 1989, 7 (06) : 411 - 419